Ownership and insider activity for Myomo, Inc. (MYO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities.
Price
| Price | $1.29 |
| Market Cap | $50M |
| Exchange | AMEX |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $797174 | $13.0M | $6.5M | $4.5M | $12.2M | $15.5M | $5.3M | $6.9M | $24.4M | $14.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.0M | $492990 | $4.3M |
| Receivables | $114506 | $297039 | $382258 | $424287 | $924916 | $2.0M | $1.9M | $2.4M | $3.8M | $4.1M |
| Inventory | $82435 | $201155 | $256149 | $439533 | $707114 | $808308 | $1.4M | $1.8M | $3.2M | $3.1M |
| Total Current Assets | $1.1M | $13.8M | $7.9M | $6.1M | $14.4M | $19.1M | $9.2M | $13.7M | $32.8M | $27.6M |
| Property, Plant & Equipment | $21563 | $77150 | $187513 | $154972 | $263807 | $908195 | $703026 | $839348 | $8.9M | $6.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.6M |
| Total Assets | $1.7M | $14.0M | $8.3M | $6.6M | $14.7M | $20.1M | $10.2M | $14.6M | $42.2M | $38.6M |
| Accounts Payable | $311085 | $264890 | $426727 | $450101 | $180499 | $723352 | $569681 | $1.1M | $1.2M | $1.5M |
| Short-term Debt | $2.1M | 0 | 0 | $1.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $3.0M | $1.5M | $1.9M | $3.9M | $2.9M | $4.3M | $3.6M | $5.5M | $10.2M | $8.3M |
| Long-term Debt | $3.4M | 0 | 0 | $888961 | 0 | 0 | 0 | 0 | 0 | $11.2M |
| Total Liabilities | $19.2M | $1.5M | $1.9M | $4.8M | $3.1M | $4.7M | $3.8M | $5.6M | $17.5M | $27.2M |
| Retained Earnings | -$22.9M | -$35.0M | -$45.3M | -$56.1M | -$67.7M | -$78.1M | -$88.8M | -$96.9M | -$103.1M | -$118.7M |
| Total Equity | -$17.5M | $12.4M | $6.4M | $1.8M | $11.6M | $15.4M | $6.4M | $9.0M | $24.7M | $11.4M |
| Total Debt | $5.5M | 0 | 0 | $2.7M | $173437 | $735002 | $553908 | $601303 | $8.1M | $19.4M |
| Net Debt | $4.7M | -$13.0M | -$6.5M | -$1.8M | -$12.1M | -$14.8M | -$4.8M | -$8.3M | -$16.8M | $988630 |
| Working Capital | -$1.9M | $12.4M | $6.0M | $2.3M | $11.6M | $14.8M | $5.6M | $8.2M | $22.6M | $19.2M |
Financial Health
| Debt / Equity | 3.44 |
| Current Ratio | 2.31 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.04 |
Profitability
| Return on Equity | -142.02% |
| Return on Invested Capital | -45.17% |
| Return on Assets | -41.05% |
| Gross Margin | 68.35% |
| Operating Margin | -27.05% |
| Net Margin | -33.53% |
Related companies: ECOR · HYPD · IGC · MIRA · MLSS · MODD · NMTC
Explore sector: Healthcare · Medical - Devices
More sections of MYO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks